Jiang Yang

Title: Jiang Yang: Innovator in Cancer-Targeted Therapeutics

Introduction

Jiang Yang is a prominent inventor based in West Lafayette, IN (US). He has made significant contributions to the field of cancer therapeutics through his innovative research and development of engineered liposomes. His work focuses on creating targeted treatments that can improve the efficacy of cancer therapies.

Latest Patents

Jiang Yang holds a patent for "Engineered liposomes as cancer-targeted therapeutics." This patent describes liposomes that are designed to target cancer cells specifically. The liposomes are equipped with ligands, such as EGFR ligands and ICAM-1 ligands, which are conjugated to their surfaces. The molecular ratio of these ligands is tailored to match the density of overexpressed proteins on the surface of targeted cancer cells, enhancing the therapeutic effect.

Career Highlights

Jiang Yang is affiliated with the Children's Medical Center Corporation, where he continues to advance his research in cancer-targeted therapies. His work has the potential to revolutionize how cancer is treated, making it more effective and less harmful to healthy cells.

Collaborations

Some of Jiang Yang's notable coworkers include Debra Auguste and Peng Guo. Their collaborative efforts contribute to the innovative research environment that fosters groundbreaking discoveries in medical science.

Conclusion

Jiang Yang's contributions to cancer-targeted therapeutics exemplify the impact of innovative research in medicine. His patented work on engineered liposomes represents a significant advancement in the fight against cancer.